Nanotech Investing

Longeveron to Present at the Emerging Growth Virtual Conference on June 12, 2024

Nanotech Investing

Veru to Present at the American Diabetes Association's 84th Scientific Sessions

Nanotech Investing

Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor

Nanotech Investing

Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers

Nanotech Investing

Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Nanotech Investing

Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology Annual Meeting

Nanotech Investing

Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib

Nanotech Investing

Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences

Nanotech Investing

Longeveron® to Attend BIO International Convention 2024

Nanotech Investing

Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit

Nanotech Investing

Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024

Nanotech Investing

Sona Nanotech Touts "Superior" Results from Animal Study for Cancer Therapy, Eyes In-human Study

Nanotech Investing

Latest nanotech News

More nanotech News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES
×